CALR and Bone marrow hypocellularity: As the CALR mutations have been shown to be early mutations residing in the highly undifferentiated HSC (21), a strong CALRmut-specific immune response in patients may be of concern, as a strong immune response could potentially eradicate all CALRmut HSC in the patients, and thus, result in bone marrow failure.